Former Chief Executive Officer · Immunome Inc. (IMNM)

Purnanand Sarma

A named executive officer of Immunome in every fiscal year CompBrief holds from FY2019 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,437,295

Salary $440,820Bonus $210,600

FY2022: $990,309

4th of 4 named executive officers at Immunome by FY2023 total.

4 named officers on file for Immunome, FY2023

Purnanand Sarma’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Immunome’s whole pay program stands against its peers

  • Immunome’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IMNM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2024 (DEF 14A).

Free

Get Purnanand Sarma’s full pay file as a PDF — free

More than this page: up to 10 years of Purnanand’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Purnanand Sarma compensation by year

Immunome Summary Compensation Table · all 5 fiscal years held
In US dollars, as Immunome reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021FY2022FY2023
Salary$233,333$435,000$540,000$540,000$440,820
Bonus$0$0$0$0$210,600
Stock awards$0$0$0$0—
Option awards$0$1,037,560$1,371,370$221,333$38,242
Non-equity incentive$81,666$211,561$189,000$216,000—
Pension and deferred compensation$0$0$0$0—
All other$24,911$10,881$12,478$12,976$741,238
Total$339,910$1,695,002$2,111,914$990,309$1,437,295

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Immunome Inc. DEF 14A filed April 26, 2024, accession 0001140361-24-022426, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Immunome Inc. filed document, accession 0001140361-24-022426. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2024.

$340K
$1.7M
$2.1M
$990K
$1.4M
FY19
FY20
FY21
FY22
FY23
SalaryBonusNon-equity incentiveOption awardsAll other

Immunome’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Clay SiegallPresident, Chief Executive Officer and Chairman of the Board$14,866,831
Bob LechleiderChief Medical Officer$2,915,362
Jack HigginsChief Scientific Officer$1,840,854
Purnanand Sarma · this pageFormer Chief Executive Officer$1,437,295

The full Immunome compensation record

free company brief

This page is one person within Immunome's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Immunome's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Purnanand Sarma's compensation dossier · One-time report. No refunds.